Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | DRUG | EIKN | ||
| Company | Gracell Biotechnologies Inc ADR | Bright Minds Biosciences Inc | Eikon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.26 | 77.27 | 13.00 | ||
| High | 10.28 | 81.62 | 13.44 | ||
| Low | 10.17 | 73.78 | 12.51 | ||
| Latest | 10.25 | 77.47 | 13.25 | ||
| Change | +0.01 | -0.17 | +0.07 | ||
| % Change | +0.05% | -0.22% | +0.53% | ||
| Volume | 6,417,100 | 269,800 | 377,600 | ||
| 20-Day Average Volume | 1,332,340 | 193,960 | 276,080 | ||
| Previous Close | 10.25 | 77.64 | 13.18 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 86.65 | 10.54 | ||
| 20-Day Raw Stochastic | 53.16% | 19.92% | 95.54% | ||
| 20-Day Relative Strength | 72.75 | 41.90 | 60.46 | ||
| Weighted Alpha | +228.20 | +95.21 | N/A | ||
| Today's Opinion | 100% Buy | 24% Buy | N/A | ||
| Previous Opinion | 100% Buy | 32% Buy | N/A | ||
| Last Month's Opinion | 100% Buy | 56% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | -9.39% since 05/08/26 | +33.03% since 05/08/26 | ||
| Low | 10.09 on 02/16/24 | 73.78 on 05/15/26 | 9.89 on 05/11/26 | ||
| High | 10.35 on 02/14/24 | 87.00 on 05/11/26 | 13.50 on 05/14/26 | ||
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | -13.56% since 04/15/26 | +22.23% since 04/15/26 | ||
| Low | 9.97 on 01/22/24 | 73.78 on 05/15/26 | 7.90 on 04/28/26 | ||
| High | 10.44 on 02/09/24 | 92.39 on 04/17/26 | 13.50 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | -0.55% since 02/13/26 | -11.96% since 02/13/26 | ||
| Low | 3.80 on 11/28/23 | 66.20 on 03/30/26 | 7.90 on 04/28/26 | ||
| High | 10.44 on 02/09/24 | 92.39 on 04/17/26 | 16.50 on 02/19/26 | ||
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | +33.82% since 11/14/25 | N/A since 02/05/26 | ||
| Low | 2.10 on 10/04/23 | 56.65 on 11/21/25 | 7.90 on 04/28/26 | ||
| High | 10.44 on 02/09/24 | 123.75 on 01/06/26 | 17.40 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 753,953 | 717,342 | ||
| Shares Outstanding, K | 72,678 | 9,732 | 54,139 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -88,080,000 | -8,740,000 | -324,248,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -9,270,000 | -5,430,000 | -82,958,000 | ||
| 60-Month Beta | -0.33 | -5.35 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | -0.70 on 02/12/26 | -2.46 on 05/11/26 | ||
| Earnings Date | 03/11/24 | 05/21/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||